Alexium International Group Limited Share Price Deutsche Boerse AG
Equities
E7T
AU000000AJX6
Specialty Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 EUR | 0.00% | +20.00% | -40.00% |
07/05 | Alexium International Group Completes Entitlement Offer | MT |
26/04 | Transcript : Alexium International Group Limited, Q3 2024 Earnings Call, Apr 26, 2024 |
Sales 2022 | 8.17M 7.63M 681M | Sales 2023 | 7.21M 6.73M 601M | Capitalization | 5.64M 5.27M 470M |
---|---|---|---|---|---|
Net income 2022 | -3M -2.8M -250M | Net income 2023 | -2M -1.87M -167M | EV / Sales 2022 | 1.65 x |
Net Debt 2022 | 2.82M 2.63M 235M | Net Debt 2023 | 4.17M 3.9M 348M | EV / Sales 2023 | 1.36 x |
P/E ratio 2022 |
-3.17
x | P/E ratio 2023 |
-1.9
x | Employees | 29 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 86.87% |
Latest transcript on Alexium International Group Limited
1 week | +20.00% | ||
3 months | -25.00% | ||
6 months | -45.45% | ||
Current year | -40.00% |
Managers | Title | Age | Since |
---|---|---|---|
Billy Blackburn
CEO | Chief Executive Officer | - | 01/22/01 |
Robert Brookins
CTO | Chief Tech/Sci/R&D Officer | - | 26/10/26 |
Richard Estes
CTO | Chief Tech/Sci/R&D Officer | - | 12/18/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Moore
CHM | Chairman | - | 01/20/01 |
Robert Brookins
CTO | Chief Tech/Sci/R&D Officer | - | 26/10/26 |
Paul Stenson
BRD | Director/Board Member | 62 | 15/20/15 |
Date | Price | Change |
---|---|---|
28/24/28 | 0.003 | 0.00% |
27/24/27 | 0.003 | 0.00% |
26/24/26 | 0.003 | 0.00% |
25/24/25 | 0.003 | +20.00% |
24/24/24 | 0.0025 | 0.00% |
Delayed Quote Deutsche Boerse AG, June 28, 2024 at 11:40 am IST
More quotes1st Jan change | Capi. | |
---|---|---|
+19.99% | 67.97B | |
-6.03% | 45.92B | |
+22.27% | 43.74B | |
+33.20% | 28.16B | |
+8.15% | 19.17B | |
+14.71% | 17.12B | |
-13.18% | 14.73B | |
-27.99% | 14.52B | |
-32.33% | 11.64B |
- Stock Market
- Equities
- AJX Stock
- E7T Stock